Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 451 to 500 of 903 results for mental

  1. Stroke rehabilitation in adults (NG236)

    This guideline covers rehabilitation after stroke for over 16s. It aims to ensure people are assessed for common problems and conditions linked to stroke, and get the care and therapy they need. It includes recommendations on the organisation and delivery of rehabilitation in hospital and the community.

  2. Patient group directions (MPG2)

    This guideline covers good practice for developing, authorising, using and updating patient group directions. It also offers advice on deciding whether a patient group direction is needed.

  3. Bronchiectasis (non-cystic fibrosis), acute exacerbation: antimicrobial prescribing (NG117)

    This guideline sets out an antimicrobial prescribing strategy for managing and preventing acute exacerbations of bronchiectasis (non-cystic fibrosis). It aims to optimise antibiotic use and reduce antibiotic resistance.

  4. Headaches in over 12s: diagnosis and management (CG150)

    This guideline covers the diagnosis and management of tension-type headache, migraine (including migraine with aura and menstrual-related migraine), cluster headache and medication overuse headache in young people (aged 12 years and older) and adults. It aims to improve the recognition and management of headaches, with more targeted treatment to improve the quality of life for people with headaches, and to reduce unnecessary investigations.

  5. Donor milk banks: service operation (CG93)

    This guideline covers how donor milk banks should recruit, screen and support women who donate breast milk. It also covers how milk banks should handle and process the breast milk they receive from donors. It aims to improve the safety of donor milk and operation of donor milk services.

  6. What risk factors predict the onset of substance misuse in young people with psychosis?

    Source guidance details Comes from guidance Coexisting severe mental illness (psychosis) and substance misuse: assessment and management...

  7. Cannabidiol for treating seizures caused by tuberous sclerosis complex (TA873)

    Evidence-based recommendations on cannabidiol (Epidyolex) for treating seizures caused by tuberous sclerosis complex.

  8. Are psychosocial interventions clinically and cost effective when compared with standard care for people with psychosis and coexisting substance misuse?

    Source guidance details Comes from guidance Coexisting severe mental illness (psychosis) and substance misuse: assessment and management...

  9. Are environmental interventions clinically and cost effective when compared with standard care for people with psychosis and coexisting substance misuse?

    Source guidance details Comes from guidance Coexisting severe mental illness (psychosis) and substance misuse: assessment and management...

  10. What service delivery models allow people with psychosis and coexisting substance misuse to remain living outside hospital?

    Source guidance details Comes from guidance Coexisting severe mental illness (psychosis) and substance misuse: assessment and management...

  11. Is clozapine clinically and cost effective when compared with other pharmacological interventions for people with psychosis and coexisting substance misuse?

    Source guidance details Comes from guidance Coexisting severe mental illness (psychosis) and substance misuse: assessment and management...

  12. What and how should training be provided to healthcare professionals working with people with psychosis and substance misuse?

    Source guidance details Comes from guidance Coexisting severe mental illness (psychosis) and substance misuse: assessment and management...

  13. Is providing treatment for psychosis and substance misuse services within staffed accommodation more cost-effective than a combination of hospital and home treatment?

    Source guidance details Comes from guidance Coexisting severe mental illness (psychosis) and substance misuse: assessment and management...

  14. Are interventions for psychosis or substance misuse clinically and cost effective when compared with standard care for people with psychosis and coexisting substance misuse?

    Source guidance details Comes from guidance Coexisting severe mental illness (psychosis) and substance misuse: assessment and management...

  15. Are interventions for psychosis or substance misuse clinically and cost effective when compared with standard care for people with psychosis and coexisting substance misuse?

    Source guidance details Comes from guidance Coexisting severe mental illness (psychosis) and substance misuse: assessment and management...

  16. What are the prevalence, risk and protective factors, and course of illness for different combinations of psychosis and coexisting substance misuse (for example, schizophrenia and cannabis misuse or bipolar disorder and alcohol misuse)?

    Source guidance details Comes from guidance Coexisting severe mental illness (psychosis) and substance misuse: assessment and management...

  17. Ectopic pregnancy and miscarriage: diagnosis and initial management (NG126)

    This guideline covers diagnosing and managing ectopic pregnancy and miscarriage in women with complications, such as pain and bleeding, in early pregnancy (that is, up to 13 completed weeks of pregnancy). It aims to improve how early pregnancy loss is diagnosed, and the support women are given, to limit the psychological impact of their loss.

  18. Type 2 diabetes in adults: management (NG28)

    This guideline covers care and management for adults (aged 18 and over) with type 2 diabetes. It focuses on patient education, dietary advice, managing cardiovascular risk, managing blood glucose levels, and identifying and managing long-term complications.

  19. Hip fracture in adults (QS16)

    This quality standard covers diagnosing and managing hip fracture in adults (aged 18 and over). It describes high-quality care in priority areas for improvement.

  20. Lifelight First for monitoring vital signs (MIB213)

    NICE has developed a medtech innovation briefing (MIB) on Lifelight First for monitoring vital signs .

  21. Newly recommended CBT therapies could help children and young people deal with anxiety

    NICE conditionally recommends digital cognitive behaviour therapies (CBT) for use in the NHS to help children and young people with symptoms of mild to moderate anxiety

  22. Views on transitions to secondary school: What are the views and experiences of children about moving to secondary school?

    Source guidance details Comes from guidance Social, emotional and mental wellbeing in primary and secondary education Number NG223

  23. Endoscopic radiofrequency ablation for gastro-oesophageal reflux disease (IPG461)

    Evidence-based recommendations on endoscopic radiofrequency ablation for gastro-oesophageal reflux disease. This involves using heat from electrodes to change the tissues in the oesophagus, with the aim of reducing symptoms.

  24. Selective internal radiation therapy for neuroendocrine tumours that have metastasised to the liver (IPG786)

    Evidence-based recommendations on selective internal radiation therapy for neuroendocrine tumours that have metastasised to the liver. This involves injecting tiny radioactive spheres into the blood vessels that supply the liver metastases.

  25. What are the most effective and cost-effective interventions to challenge stereotypes and change employers' and workforce attitudes towards older employees?

    benefits for them and society. Reducing negative attitudes may also improve mental health and wellbeing and reduce distress arising from...

  26. Support for transitions: What do children and young people, including those from underserved populations, find useful to support life changes in the context of their education?

    Source guidance details Comes from guidance Social, emotional and mental wellbeing in primary and secondary education Number NG223

  27. Promoting physical exercise, and a healthy diet and lifestyle: What interventions are effective in promoting physical exercise, and a healthy diet and lifestyle, in looked-after children, young people and care leavers?

    discussion are in evidence review F: interventions to promote physical, mental, and emotional health and wellbeing of looked-after...

  28. Pregnancy and complex social factors: a model for service provision for pregnant women with complex social factors (CG110)

    This guideline covers antenatal care for all pregnant women with complex social factors (particularly alcohol or drug misuse, recent migrant or asylum seeker status, difficulty reading or speaking English, aged under 20, domestic abuse). It offers advice on improving access to care, maintaining contact with antenatal carers, and additional information and support for these women.

  29. Oesophago-gastric cancer: assessment and management in adults (NG83)

    This guideline covers assessing and managing oesophago-gastric cancer in adults, including radical and palliative treatment and nutritional support. It aims to reduce variation in practice through better organisation of care and support, and improve quality of life and survival by giving advice on the most suitable treatments depending on cancer type, stage and location.

  30. Crohn's disease: management (NG129)

    This guideline covers managing Crohn’s disease in children, young people and adults. It aims to reduce people’s symptoms and maintain or improve their quality of life.

  31. For people with generalised anxiety disorder (GAD) who are ready to start a low-intensity intervention, what is the clinical effectiveness of physical activity compared with waiting-list control?

    anxiety. As generalised anxiety disorder (GAD) is a commonly experienced mental health disorder the results of this study will have...

  32. Identification of factors associated with suicide:- What factors are associated with suicide attempts and completed suicides?

    prevention. Source guidance details Comes from guidance Mental health of adults in contact with the criminal justice system Number

  33. Smoking: acute, maternity and mental health services (PH48)

    This guideline has been updated and replaced by the NICE guideline on tobacco: preventing uptake, promoting quitting and treating dependence (NG209).

  34. Axicabtagene ciloleucel for treating relapsed or refractory diffuse large B-cell lymphoma after first-line chemoimmunotherapy (TA895)

    Evidence-based recommendations on axicabtagene ciloleucel (Yescarta) for treating relapsed or refractory diffuse large B-cell lymphoma after first-line chemoimmunotherapy.

  35. Factors affecting participation and quality of life:- What are the key factors, including additional care and support, that influence participation and quality of life in people with neuropathic pain?

    suggesting that people with neuropathic pain experience poorer physical and mental health than people with other forms of pain, even...

  36. Axitinib for treating advanced renal cell carcinoma after failure of prior systemic treatment (TA333)

    Evidence-based recommendations on axitinib (Inlyta) for previously treated advanced renal cell carcinoma in adults.

  37. Prosthetic intervertebral disc replacement in the cervical spine (IPG341)

    Evidence-based recommendations on prosthetic intervertebral disc replacement in the cervical spine. This involves removing the damaged disc and inserting an artificial disc in its place.

  38. What are the risks that predict the development of blood-borne virus infections in people with complex psychosis in the UK?

    the relatively high prevalence of hepatitis and HIV in people with severe mental illness. The committee agreed this may be related to...

  39. Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain (NG193)

    This guideline covers assessing all chronic pain (chronic primary pain, chronic secondary pain, or both) and managing chronic primary pain in people aged 16 years and over. Chronic primary pain is pain with no clear underlying cause, or pain (or its impact) that is out of proportion to any observable injury or disease.

  40. Deep brain stimulation for refractory chronic pain syndromes (excluding headache) (IPG382)

    Evidence-based recommendations on deep brain stimulation for refractory chronic pain syndromes (excluding headache). This involves stimulating a precise area of the brain using an electrode to treat the chronic pain.

  41. Percutaneous transforaminal endoscopic lumbar discectomy for sciatica (IPG556)

    Evidence-based recommendations on percutaneous transforaminal endoscopic lumbar discectomy for sciatica in adults. This involves removing part of the damaged spinal disc to relieve the symptoms of sciatica.

  42. Intravenous fluid therapy in adults in hospital (CG174)

    This guideline covers the general principles for managing intravenous (IV) fluid therapy in hospital inpatients aged 16 and over with a range of conditions. It aims to help prescribers understand the optimal amount and composition of IV fluids to be administered and the best rate at which to give them, to improve fluid prescribing and outcomes among people in hospital. It does not cover pregnant women, and those with severe liver or renal disease, diabetes or burns.

  43. Blood transfusion (NG24)

    This guideline covers the assessment for and management of blood transfusions in adults, young people and children over 1 year old. It covers the general principles of blood transfusion, but does not make recommendations relating to specific conditions.

  44. Advance statements and decisions:- What forms of management of violence and aggression do service users prefer and do advance statements and decisions have an important role in management and prevention?

    Comes from guidance Violence and aggression: short-term management in mental health, health and community settings Number NG10 Date

  45. What are the key factors, including additional care and support, that influence participation* and quality of life in people with neuropathic pain?

    suggesting that people with neuropathic pain experience poorer physical and mental health than people with other forms of pain, even...

  46. What is the impact of coexisting physical health conditions on the mortality of people with complex psychosis?

    committee also drew on the evidence identifying the most common physical and mental health comorbidities to highlight conditions that...

  47. Priority of treatment for people with anxiety and depression:- For people with both anxiety and depression, which disorder should be treated first to improve their outcomes?

    follow-up. Source guidance details Comes from guidance Common mental health problems: identification and pathways to care Number

  48. Violence related to drug or alcohol misuse:- What is the best environment in which to contain violence in people who have misused drugs or alcohol?

    Comes from guidance Violence and aggression: short-term management in mental health, health and community settings Number NG10 Date

  49. What are the benefits of a primary care-based collaborative care approach to improving the treatment of generalised anxiety disorder (GAD) compared with usual care?

    collaborative care approach involving GPs, other primary care practitioners and mental health professionals, can improve the uptake of...

  50. Medication for promoting de-escalation:- Which medication is effective in promoting de-escalation in people who are identified as likely to demonstrate significant  violence?

    Comes from guidance Violence and aggression: short-term management in mental health, health and community settings Number NG10 Date